Burden of hypereosinophilic syndromes in the United States: Patients’ perspective
People with HES face long diagnostic journeys. The findings in this study highlight the heterogeneous symptoms, challenges, and multifactorial burden they experience, providing a voice for patients with HES and enhancing physician awareness to support improved diagnostics and management.
Authors
- Cara Schmitt
- Waseem Ahmed (ORCID: https://orcid.org/0000-0002-5587-7964)
- Anna Kovalszki (ORCID: https://orcid.org/0000-0002-1561-1977)
- Dan Gratie
- Arijita Deb (ORCID: https://orcid.org/0000-0002-4570-0364)
- Jared Silver (ORCID: https://orcid.org/0000-0002-7838-0985)
- Mary Jo Strobel
- A. Edgecomb
Institutions
- University of Michigan (US)
- Health Outcomes Solutions (United States) (US)
- Cell and Gene Therapy Catapult (GB)
- American Partnership for Eosinophilic Disorders (US)
- Telesage (United States) (US)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1016/j.jacig.2025.100501
- Citations
- 1
- Primary Topic
- Eosinophilic Disorders and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- GlaxoSmithKline